1. US
Department of Health and
Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Office of Regulatory Affairs (ORA), Guidance for Industry. PAT—A Framework for Innovative Pharmaceutical
Development, Manufacturing, and Quality Assurance, Pharmaceutical CGMPs, Rockville,
MD, September 2004, https://www.fda.gov/downloads/drugs/guidances/ucm070305.pdf, accessed on April 18, 2019.
2. US Department of Health and
Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Guidance for Industry. Quality
Considerations for Continuous Manufacturing, Draft Guidance,
Pharmaceutical Quality/CMC, Pharmaceutical
Quality/Manufacturing Standard (CGMP), Rockville, MD, February 2019, https://www.fda.gov/media/121314/download, accessed April 4, 2019.
3. The Future of Pharmaceutical Manufacturing Sciences
4. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing
5. Advances in downstream processing of biologics – Spectroscopy: An emerging process analytical technology